Company: MIRA
Filing Date: 2025-07-29
Form Type: PRER14A
Source: 0001641172-25-021434
Chunk: 118

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-07-29
Form: PRER14A
Chunk 118
---
, and other information regarding issuers that file electronically with the SEC, including the Company.

<div align='center'>INFORMATION INCORPORATED BY REFERENCE</div>

This proxy statement incorporates by reference the documents listed below that MIRA has previously filed with the SEC (other than, in each case, documents or information deemed to have been furnished and not filed in accordance with SEC rules). They contain important information about MIRA and its financial condition.

| ● 
 ● | Annual                                                                                                                                                                         
 Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on March                                                                                   
 28, 2025.                                                                                                                                                                      
 Quarterly                                                                                                                                                                      
 Report on Form 10-Q for the for the quarterly period ended March 31, 2025 filed with the                                                                                       
 SEC on May 14, 2025;                                                                                                                                                           |
|:--|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| ● | Current                                                                                                                                                                        
 Reports on Form 8-K filed with the SEC on April 1, 2025, April 11, 2025, April 16, 2025,                                                                                       
 April 23, 2025, May 6, 2025, May 8, 2025, May 21, 2025; May 28, 2025; June 17, 2025, June 24, 2025, June 30, 2025, July 2, 2025, July 8, 2025, and July 10, 2025;              |
| ● | the                                                                                                                                                                            
 description of MIRA’s common stock contained in its registration statement on Form 8-A, filed with the SEC on July 31, 2023 including all amendments and reports filed for the 
 purpose of updating such description.                                                                                                                                          |

To the extent that any information contained in any report on Form 8-K, or any exhibit thereto, was furnished to, rather than filed with, the SEC by MIRA, such information or exhibit is specifically not incorporated by reference.

In addition, MIRA incorporates by reference any future filings it may make with the SEC under Section 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this proxy statement and before the date of the MIRA Annual Meeting (excluding any current reports on Form 8-K to the extent disclosure is furnished and not filed). Those documents are considered to be a part of this proxy statement,